Insider trades
William L. Macias, Chief Officer of Immunovant IMVT, has filed 0 purchases and 31 sales on the open market. The latest trade was on 25/02/19.
William L. Macias
Chief Medical Officer
- Company
- Immunovant IMVT
- First filing
- 23/02/03
- Trades
- 35 trades
- Buys / sales
- 0 / 31
- 12-month net buying
- No record
- Last trade
- 25/02/19
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
ImmunovantIMVT | Open-market sale | 25/02/19 | 25/02/21 | 2,055 sh | $20.86 | $42,867.3 | −0.6% |
| Open-market sale | 25/01/15 | 25/01/17 | 2,383 sh4 trades | $23.83avg. | $56,782.17 | −0.7% | |
ImmunovantIMVT | Open-market sale | 24/11/20 | 24/11/22 | 3,353 sh | $25.45 | $85,333.85 | −0.9% |
| Open-market sale | 24/10/16 | 24/10/18 | 3,188 sh2 trades | $28.79avg. | $91,782.52 | −0.9% | |
| Open-market sale | 24/08/21 | 24/08/23 | 3,027 sh2 trades | $31.86avg. | $96,437.28 | −0.8% | |
| Open-market sale | 24/07/17 | 24/07/19 | 3,044 sh4 trades | $29.69avg. | $90,386.14 | −0.8% | |
ImmunovantIMVT | Open-market sale | 24/05/22 | 24/05/24 | 3,247 sh | $29.65 | $96,273.55 | −0.9% |
| Open-market sale | 24/04/17 | 24/04/19 | 8,280 sh4 trades | $29.06avg. | $240,601.5 | −2.1% | |
ImmunovantIMVT | Open-market sale | 24/02/22 | 24/02/23 | 2,221 sh | $36.15 | $80,289.15 | −0.7% |
ImmunovantIMVT | Open-market sale | 24/01/18 | 24/01/19 | 424 sh | $41.03 | $17,396.72 | −0.1% |
| Open-market sale | 23/11/22 | 23/11/24 | 3,265 sh2 trades | $32.78avg. | $107,024.23 | −1.0% | |
ImmunovantIMVT | Open-market sale | 23/10/19 | 23/10/20 | 530 sh | $36.80 | $19,504 | −0.2% |
| Open-market sale | 23/08/24 | 23/08/25 | 12,333 sh2 trades | $20.30avg. | $250,360.49 | −3.5% | |
ImmunovantIMVT | Open-market sale | 23/07/19 | 23/07/20 | 426 sh | $24.94 | $10,624.44 | −0.1% |
ImmunovantIMVT | Open-market sale | 23/04/25 | 23/04/26 | 509 sh | $16.29 | $8,291.61 | −0.1% |
ImmunovantIMVT | Open-market sale | 23/02/02 | 23/02/03 | 537 sh | $18.24 | $9,794.88 | −0.2% |
| Open-market sale | 23/01/11 | 23/01/13 | 44,568 sh2 trades | $16.75avg. | $746,317.2 | −14.5% |